GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 3b [2] | TH-302
Compound class:
Synthetic organic
Comment: Evofosfamide is a hypoxia-activated prodrug being investigated as an antineoplastic therapeutic (compound 3b in [2]). This compound is related to ifosfamide. Being developed by Threshold Pharmaceuticals.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9811 | evofosfamide |
Synonyms ![]() |
|
| compound 3b [2] | TH-302 | |
Database Links ![]() |
|
| CAS Registry No. | 918633-87-1 (source: PubChem) |
| ChEMBL Ligand | CHEMBL260046 |
| GtoPdb PubChem SID | 252166895 |
| PubChem CID | 11984561 |
| Search Google for chemical match using the InChIKey | UGJWRPJDTDGERK-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | UGJWRPJDTDGERK |
| Search PubMed clinical trials | evofosfamide |
| Search PubMed titles | evofosfamide |
| Search PubMed titles/abstracts | evofosfamide |
| UniChem Compound Search for chemical match using the InChIKey | UGJWRPJDTDGERK-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | UGJWRPJDTDGERK-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Evofosfamide (links to external site)
Cat. No. HY-10535 |